(November 14, 2017, 12:59 PM EST) -- PHILADELPHIA — A Pennsylvania appeals panel on Nov. 13 affirmed defense summary judgment in two Risperdal gynecomastia cases, ruling that the plaintiffs reasonably should have known that their alleged injuries were caused by the drug before they filed suit a minimum of six years too late (Jonathan Saksek v. Janssen Pharmaceuticals, Inc., et al., No. 576 EDA 2015, Joshua Winter v. Janssen Pharmaceuticals, Inc., et al., No. 590 EDA 2015, Pa. Super., 2017 Pa. Super. Unpub. LEXIS 4163)....